Warning: This security is no longer trading.
Akebia Therapeutics and Keryx Biopharmaceuticals complete merger
Keryx Biopharmaceuticals, Inc. (KERX): Price and Financial Metrics
KERX Price/Volume Stats
| Current price | $3.36 | 52-week high | $5.98 |
| Prev. close | $3.43 | 52-week low | $2.47 |
| Day low | $2.96 | Volume | 2,596,000 |
| Day high | $3.46 | Avg. volume | 1,157,610 |
| 50-day MA | $3.03 | Dividend yield | N/A |
| 200-day MA | $3.97 | Market Cap | 344.00M |
KERX Stock Price Chart Interactive Chart >
Keryx Biopharmaceuticals, Inc. (KERX) Company Bio
Keryx Biopharmaceuticals is focused on bringing innovative therapies to market for patients with renal disease. The company was founded in 1997 and is based in New York, New York.
KERX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...